NEW YORK, Oct. 1 - Orchid Biosciences has said it will acquire DNA analysis company Lifecodes in a $12.6 million all-stock deal, Orchid said on Monday.  

Terms of the agreement, which have been approved by both firms’ boards of directors, call for Orchid to issue roughly 6.5 million new shares of common stock in exchange for all of Lifecodes’ outstanding equity.  

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.